Profile
Marc J.
Centrella worked as a Senior Director of Corporate Development & Strategy at Becton, Dickinson & Co. from 2015 to 2018.
Prior to that, he was the Director of Corporate Development at Catalent Pharma Solutions, Inc. from 2013 to 2015.
He also worked as the Vice President of Business Development & Strategy at Repligen Corp.
Mr. Centrella received his undergraduate degree from Ramapo College of New Jersey in 2004.
Former positions of Marc J. Centrella
Companies | Position | End |
---|---|---|
BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01/05/2018 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | 01/02/2015 |
REPLIGEN CORPORATION | Corporate Officer/Principal | - |
Training of Marc J. Centrella
Ramapo College of New Jersey | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
REPLIGEN CORPORATION | Health Technology |
BECTON, DICKINSON AND COMPANY | Health Technology |
Private companies | 1 |
---|---|
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
- Stock Market
- Insiders
- Marc J. Centrella